Table 2. IEMG during the pre-activation phase (unit: %MVC).
|
175g |
255g |
335g |
415g |
p-value |
| Vastus lateralis |
5±0.01 |
4±0.01 |
4±0.02 |
4±0.01 |
0.738 |
| Vastus medialis |
5±0.02 |
4±0.01 |
4±0.01 |
5±0.01 |
0.302 |
| Rectus femoris |
8±0.04 |
8±0.03 |
9±0.04 |
9±0.03 |
0.339 |
| Biceps femoris |
21±0.04 |
22±0.04 |
23±0.07 |
20±0.04 |
0.126 |
| Semitendinosus |
20±0.03 |
20±0.04 |
22±0.06 |
21±0.05 |
0.362 |
| Tibialis anterior |
28±0.05 |
20±0.08 |
24±0.10 |
24±0.08 |
0.008* |
| Gastrocnemius lateralis |
8±0.04 |
8±0.04 |
8±0.04 |
9±0.04 |
0.932 |
| Gastrocnemius medialis |
7±0.03 |
7±0.05 |
7±0.06 |
8±0.08 |
0.987 |
| Soleus muscles |
7±0.03 |
5±0.04 |
6±0.04 |
6±0.04 |
0.312 |
* Significant differences (p<0.05) between shoes of different mass during the pre-activation phase.
